To ATCC Valued Customers,

ATCC stands ready to support our customers’ needs during the coronavirus pandemic. If you experience any issues with your products or services, please contact ATCC Customer Service at For Technical questions please contact Thank you.

MDA-MB-453 Purified Genomic DNA, Quantitative (PIK3CA Mutant), 3 µg (ATCC® HTB-131DQ)

Focus: Oncology  / 

Permits and Restrictions

View Permits View Restrictions

Focus Area Oncology
Product Format frozen 3 µg, target concentration 100 ng/µL Quantitative Genomic DNA
stored in 1X TE buffer
Verified By ATCC Cell Line Authentication Service
Sanger Sequencing
Storage Conditions -20°C or colder

DNA taken from MDA-MB-453 (ATCC® HTB-131™) Cell Line and quantitated

Cell Line Description:

The MDA-MB-453 cell line is a human breast adenocarcinoma cell line

Spin down before use

Quantified for oncology biomarker PIK3CA p.H1047R via NGS and ddPCR

Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Quality Control Specifications

DNA Quality Control Information*:





DNA - M.W.

≥48 kb (or higher than uppermost band of the high MW DNA ladder)


RNA - Content

No visible RNA detected in the agarose gel


Identical STR profile to cell line source

DNA Concentration

(PicoGreen® method)

Report Results

Purity (A260/A280)

Ratio 1.7 to 2.1

Total DNA amount 

(PicoGreen® method)

≥ 3 µg

Mutation allelic frequency

Report results: NGS (Coverage > 10,000X)*

Absolute/relative gene
copies/ng DNA 

Report results: ddPCR™ (Average of nine data points)*


DNA - Digestion

Verified by restriction enzyme digestion

*Please consult the Certificate of Analysis for lot-specific test results.

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation

Unless the Purchaser has a separate license agreement with The University of Texas M. D. Anderson Cancer Center (“Institution”), the ATCC Material is subject to the following restrictions:

  1. The ATCC Material (and any Modifications, Unmodified Derivatives and/or Progeny thereof) may not be used (1) for commercial purposes or Commercial Use by any Purchaser, or (2) by for-profit or commercial entities for any purpose;
  2. Purchaser may not transfer ATCC Materials, Modifications, Unmodified Derivatives, or Progeny to any for-profit entity or commercial entity; and
  3. Purchaser may not use ATCC Materials (or any Modifications, Unmodified Derivatives and/or Progeny thereof) in connection with any research, collaboration or other activities involving a third party that is a commercial entity or for-profit entity.

The restrictions set forth above are in addition to the restrictions set forth in the ATCC Material Transfer Agreement. Capitalized terms have the meanings set forth in the ATCC Material Transfer Agreement unless otherwise indicated above.

For instructions on how to obtain a license from Institution, please contact the Institution Office of Technology Commercialization via email at